Old Mission Capital’s Nanobiotix NBTX Stock Holding History

Old Mission Capital’s Portfolio NBTX Stock Details NBTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-48,474	Closed	-$139K	–	1136
2024 Q4	$139K	Buy	+48,474	New	+$194K	﹤0.01%	870

Other funds holding NBTX

Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return

Old Mission Capital's NBTX Position: Q1 2025 in Review

Old Mission Capital sold out of Nanobiotix (NBTX) in Q1 2025, closing a stake of 48,474 shares — an estimated $139K sold.

Old Mission Capital first reported a position in NBTX in Q4 2024 and held it in 1 quarter. The position peaked at $139K in Q4 2024. 12 funds tracked by Wall St. Rank hold NBTX as of Q1 2025.

Old Mission Capital reported no remaining Nanobiotix position as of Q1 2025 after selling out during the quarter.
Old Mission Capital sold 48,474 Nanobiotix shares in Q1 2025, an estimated $139K.
Old Mission Capital first reported a position in Nanobiotix in Q4 2024 and held it in 1 quarter.
Old Mission Capital's Nanobiotix position peaked at $139K in Q4 2024.
12 funds tracked by Wall St. Rank held Nanobiotix as of Q1 2025.

Based on Old Mission Capital's 13F filing for Q1 2025, filed 15 May 2025.